- PR Newswire•yesterday
MARLBOROUGH, Mass., Jan. 18, 2017 /PRNewswire/ -- Lemelson Capital Management, LLC, a private investment management firm, today announced performance results for its flagship Amvona Fund, LP. For 2016, ...
- Capital Cube•yesterdayLigand Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : LGND-US : January 18, 2017
Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Ligand Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)
- Accesswire•6 days agoEQUITY NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Ligand Pharmaceuticals Incorporated and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 13, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Ligand Pharmaceuticals Incorporated ("Ligand" or the "Company") ...
LGND : Summary for Ligand Pharmaceuticals Incorpor - Yahoo Finance
Ligand Pharmaceuticals Incorporated (LGND)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Day's Range||100.90 - 102.32|
|52 Week Range||82.06 - 139.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||290.14|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|